Login

Paul Wright, CEO, Universal Biosensors Inc 00:00:00

Share On Facebook Share On Twitter

CEO Paul Wright discusses the company’s Q3 2015 results and product pipeline.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Accessing RSA Balances for Mortgages: Guidelines and Impact Explained by Stanbic IBTC's Executive Director | Nike Bajomo, Executive Director ,  Stanbic IBTC Holdings PLC.
00:10:00
Monika Mantilla: Unveiling the G-R-E-A-T Vision for MBEs in Access to Capital Webinar Series| Monika Mantilla,CEO,Altura Capital Group
00:10:00
4D Medical Achieves Milestone: Generates First Clinical SAS Revenue and Explores International Expansion with Revolutionary Respiratory Imaging Technology| Dr Andreas Fouras, CEO, 4dmedical ltd.
00:10:00
GGV Capital Asia Rebrands as Granite Asia, fortifying its mission to fuel purposeful growth of the region|Jixun Foo,Senior Managing Partner, Granite Asia
00:00:00
Allergy Therapeutics says US preparations are underway which include two pivotal trials - Manuel Llobert, CEO, Allergy Therapeutics
00:10:00
Teemu Suna on Revolutionizing Healthcare with Metabolomics | Teemu Suna, CEO , Nightingale Health Oyj.
00:10:00
Indicators Suggest an Imminent Recession: Colin Stewart of JC Clark Limited Analyzes Economic Risks and Debt Ceiling Negotiations
00:10:00
extensive industry insider networks to help businesses|Cristina Nunez, General Partner,True Beauty Ventures
00:00:00
Stéphane Boissel, CEO, Txcell SATXCL:PAR
00:10:00
Starting and developing something new is always challenging|Tuck Lye Koh,partner,Shunwei
00:10:00
Legacy Minerals Uncovers Untapped Potential in New South Wales with Major Partnerships and Promising Drill Results
00:10:00
"Uncovering Investment Opportunities through Value Investing in Japanese Equities: Insights from Andrew McCagg, Portfolio Manager at Nomura Asset Management"

© 2017 - Neuhu+